Health
Healthcare
Medical

BioScrip

$2.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (0.99%) Today
-$0.01 (-0.49%) After Hours

Why Robinhood?

You can buy or sell BioScrip and other stocks, options, ETFs, and crypto commission-free!

About

BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. Read More The company was founded in 1996 and is headquartered in Denver, CO.

Employees
2,043
Headquarters
Denver, Colorado
Founded
1996
Market Cap
262.73M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
931.80K
High Today
$2.10
Low Today
$2.02
Open Price
$2.04
Volume
162.49K
52 Week High
$4.14
52 Week Low
$1.56

Collections

Health
Healthcare
Medical
Pharmaceutical
Medical Devices

News

Yahoo FinanceMay 9

Here’s What Hedge Funds Think About BioScrip Inc.

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions.

1,466
NasdaqMay 9

BioScrip's Option Care Merger on Track, Q1 Loss Narrows

BioScrip Inc.BIOS released certain updates on its ongoing merger with Option Care along with its first-quarter earnings release recently. The company has entered into a merger agreement with this home and alternate site infusion services provider in March 2019. According to BioScrip, following the early termination of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 waiting period, the merger transaction with Option Care is proceeding as per plans and the company has already filed a preliminary mer...

372
StreetInsiderMay 7

Form DEFA14A BioScrip, Inc.

347

Earnings

-$0.18
-$0.13
-$0.07
-$0.02
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.